Patents by Inventor Toke Folke Christensen

Toke Folke Christensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • System for optimizing a drug dosage regimen over time
    Patent number: 10603437
    Abstract: A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value.
    Type: Grant
    Filed: March 21, 2017
    Date of Patent: March 31, 2020
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Bengtsson, Toke Folke Christensen, Louise Wagner Noergaard, Mads Schenstroem Stefansen
  • System for Optimizing a Drug Dosage Regimen Over Time
    Publication number: 20170189616
    Abstract: A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value.
    Type: Application
    Filed: March 21, 2017
    Publication date: July 6, 2017
    Inventors: Henrik Bengtsson, Toke Folke Christensen, Louise Wagner Petersen, Mads Schenstroem Stefansen
  • System for optimizing a drug dosage regimen over time
    Patent number: 9636461
    Abstract: A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value.
    Type: Grant
    Filed: May 2, 2012
    Date of Patent: May 2, 2017
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Bengtsson, Toke Folke Christensen
  • SYSTEM FOR OPTIMIZING A DRUG DOSAGE REGIMEN OVER TIME
    Publication number: 20140200545
    Abstract: A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value.
    Type: Application
    Filed: May 2, 2012
    Publication date: July 17, 2014
    Applicant: Novo Nordisk A/S
    Inventors: Henrik Bengtsson, Toke Folke Christensen, Louise Wagner Petersen, Mads Schenstroem Stefansen